<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">mvjr</journal-id><journal-title-group><journal-title xml:lang="ru">Медицинский вестник Юга России</journal-title><trans-title-group xml:lang="en"><trans-title>Medical Herald of the South of Russia</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">2219-8075</issn><issn pub-type="epub">2618-7876</issn><publisher><publisher-name>The Rostov State Medical University</publisher-name></publisher></journal-meta><article-meta><article-id custom-type="elpub" pub-id-type="custom">mvjr-1205</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>ОРИГИНАЛЬНЫЕ СТАТЬИ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>ORIGINAL ARTICLES</subject></subj-group></article-categories><title-group><article-title>Патогенетические аспекты невынашивания ранних сроков беременности</article-title><trans-title-group xml:lang="en"><trans-title>Pathogenetic Aspects of the First Trimester Miscarriage</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Дубровина</surname><given-names>С. О.</given-names></name><name name-style="western" xml:lang="en"><surname>Dubrovina</surname><given-names>S. O.</given-names></name></name-alternatives><bio xml:lang="ru"><p>344012 г. Ростов-на-Дону, ул. Мечникова 43</p></bio><bio xml:lang="en"><p>43 Mechnikova st., Rostov-on-Don, 344012</p></bio><email xlink:type="simple">s.dubrovina@gmail.com</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Маклюк</surname><given-names>А. М.</given-names></name><name name-style="western" xml:lang="en"><surname>Maklyuk</surname><given-names>A. M.</given-names></name></name-alternatives><bio xml:lang="ru"><p>344012 г. Ростов-на-Дону, ул. Мечникова 43</p></bio><bio xml:lang="en"><p>43 Mechnikova st., Rostov-on-Don, 344012</p></bio><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Линде</surname><given-names>В. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Linde</surname><given-names>V. A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>344012 г. Ростов-на-Дону, ул. Мечникова 43</p></bio><bio xml:lang="en"><p>43 Mechnikova st., Rostov-on-Don, 344012</p></bio><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Маркарьян</surname><given-names>И. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Markaryan</surname><given-names>I. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>344012 г. Ростов-на-Дону, ул. Мечникова 43</p></bio><bio xml:lang="en"><p>43 Mechnikova st., Rostov-on-Don, 344012</p></bio><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>Ростовский научно-исследовательский институт акушерства и педиатрии</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Rostov Scientific Research Institute of Obstetrics and Pediatrics</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2011</year></pub-date><pub-date pub-type="epub"><day>30</day><month>06</month><year>2011</year></pub-date><volume>0</volume><issue>2</issue><fpage>63</fpage><lpage>68</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Дубровина С.О., Маклюк А.М., Линде В.А., Маркарьян И.В., 2011</copyright-statement><copyright-year>2011</copyright-year><copyright-holder xml:lang="ru">Дубровина С.О., Маклюк А.М., Линде В.А., Маркарьян И.В.</copyright-holder><copyright-holder xml:lang="en">Dubrovina S.O., Maklyuk A.M., Linde V.A., Markaryan I.V.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://www.medicalherald.ru/jour/article/view/1205">https://www.medicalherald.ru/jour/article/view/1205</self-uri><abstract><sec><title>Цель</title><p>Цель: на основании изучения патогенетических аспектов угрозы прерывания беременности ранних сроков разработать прогностические маркеры невынашивания беременности.</p></sec><sec><title>Материалы и методы</title><p>Материалы и методы: сывороточные уровни ИЛ-2 и -6, CRH, активина А, ФНО-α, СЭФР, sFlt, ФРП исследованы с помощью ELISA у 24 беременных с угрозой аборта и неблагоприятным исходом (IV группа), у 35 - с благоприятным исходом угрозы прерывания беременности (II группа), у 21 - с неразвивающейся беременностью (III группа) и 26 - с неосложненной беременностью (контрольная группа). Использованы AtteStat 7.3, MedCalc, Microsoft Excel 2003, Statistica 6.0, критерии Спирмена и Вилкоксона.</p></sec><sec><title>Результаты</title><p>Результаты: ИЛ-2 и 6 ниже, активин А и ФНО-α выше без статистически значимых различий в первой группе по сравнению со всеми остальными группами. Только ФНО-α во II группе статистически ниже по сравнению с I группой. Во всех группах sFlt ниже по сравнению с группой контроля. СЭФР и CRH были ниже во II и III группах и выше в IV группе по сравнению с I первой группой. ФРП был выше в III группе и ниже во II и IV группах по сравнению с I группой.</p></sec><sec><title>Заключение</title><p>Заключение: в первом триместре беременности у женщин с угрозой аборта с неблагоприятным исходом в сыворотке крови различия исследуемых параметров по сравнению с неосложненной беременностью и угрозой аборта с благоприятным исходом обусловливают потери беременности.</p></sec></abstract><trans-abstract xml:lang="en"><sec><title>Purpose</title><p>Purpose: To examine the profile of cytokines and gormones in maternal serum of first-trimester pregnancies complicated by threatened abortion (TACP).</p></sec><sec><title>Materials and Methods</title><p>Materials and Methods: Serum levels of interleukin-2 and -6, tumor necrosis factor alpha (TNF-alpha), corticotropin-releasing hormone (CRH), activin A, VEGF, sFlt, PGF were measured, by ELISA, in 24 women with TACP and adverse outcome (group IV) and compared with the corresponding levels of 35 women with TACP and successful outcome (group II) and 21 miscarriage (group III) and 26 women with first-trimester uncohreatened abortionmplicated pregnancy (group I) who served as controls. AtteStat 7.3, MedCalc, Microsoft Excel 2003, Statistica 6.0, Spirmen or Wilcoxon test were used for analysis.</p></sec><sec><title>Results</title><p>Results: IL-2 and -6 were detected lower and TNF-alpha and activin A were detected higher with no significant difference in group I, compared to all other groups. Only TNF-alpha in group II were detected lower with significantly levels, compared to I group. sFlt in all groups was detected lower, compared to I group. VEGF and CRH were detected lower in II and III groups and higher in IV group, compared to I group. PGF was detected higher in III group and lower in II and IV groups, compared to I group.</p></sec><sec><title>Summary</title><p>Summary: In first-trimester TACP with adverse outcome, allteration of maternal angiogenic factors, activin A, IL and CRH levels, compared to first-trimester uncomplicated pregnancy and TACP wihreatened abortionth successful outcome, is relevant to the occurrence of miscarriages.</p></sec></trans-abstract><kwd-group xml:lang="ru"><kwd>невынашивание беременности</kwd><kwd>ангиогенез</kwd><kwd>интерлейкины</kwd><kwd>ФНО-α</kwd></kwd-group><kwd-group xml:lang="en"><kwd>missed abortion</kwd><kwd>interleukin</kwd><kwd>TNF-alpha</kwd><kwd>angiogenesis</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Серова О.Ф., Милованов А.П. Основные патоморфологические причины неразвивающейся беременности и обоснование прегравидарной терапии женщин //Акуш. и гин. – 2001. – №1. – С. 19–23.</mixed-citation><mixed-citation xml:lang="en">Серова О.Ф., Милованов А.П. Основные патоморфологические причины неразвивающейся беременности и обоснование прегравидарной терапии женщин //Акуш. и гин. – 2001. – №1. – С. 19–23.</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Jauniaux E., Burton G.J. Pathophysiology of histological changes in early pregnancy loss //Placenta. – 2005. – Vol. 26. – P. 114–123.</mixed-citation><mixed-citation xml:lang="en">Jauniaux E., Burton G.J. Pathophysiology of histological changes in early pregnancy loss //Placenta. – 2005. – Vol. 26. – P. 114–123.</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Aplin J.D. Hypoxia and human placental development //J. Clin. Invest.- 2000.- Vol. 105, №5.- P. 559-560.</mixed-citation><mixed-citation xml:lang="en">Aplin J.D. Hypoxia and human placental development //J. Clin. Invest.- 2000.- Vol. 105, №5.- P. 559-560.</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Geva E., Ginzinger D.G., Zaloudek C.J. et al. Human placental vascular development: vasculogenic and angiogenic (branching and nonbranching) transformation is regulated by vascular endothelial growth factor-A, angiopoietin-1, and angiopoietin-2 //J. Clin. Endocrinol. Metab.- 2002.- Vol. 87, №9.- P. 4213-4224.</mixed-citation><mixed-citation xml:lang="en">Geva E., Ginzinger D.G., Zaloudek C.J. et al. Human placental vascular development: vasculogenic and angiogenic (branching and nonbranching) transformation is regulated by vascular endothelial growth factor-A, angiopoietin-1, and angiopoietin-2 //J. Clin. Endocrinol. Metab.- 2002.- Vol. 87, №9.- P. 4213-4224.</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Vuorela P., Carpen O., Tulppala М., Halmesmaki Е. VEGF, its receptors and the tie receptors in recurrent miscarriage / P. // Mol. Hum. Reprod. – 2000. – Vol. 6. – P. 276–282.</mixed-citation><mixed-citation xml:lang="en">Vuorela P., Carpen O., Tulppala М., Halmesmaki Е. VEGF, its receptors and the tie receptors in recurrent miscarriage / P. // Mol. Hum. Reprod. – 2000. – Vol. 6. – P. 276–282.</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Plaiser M., Dennert I., Rost E. et al. Decidual vascularization and the expression of angiogenic growth factors and proteases in first trimester spontaneous abortions //Human reproduction. – 2009. – Vol. 24, N 1. – P. 185–197.</mixed-citation><mixed-citation xml:lang="en">Plaiser M., Dennert I., Rost E. et al. Decidual vascularization and the expression of angiogenic growth factors and proteases in first trimester spontaneous abortions //Human reproduction. – 2009. – Vol. 24, N 1. – P. 185–197.</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Arechavaleta-Velasco F., Koi H., Strauss J.F., Parry S. Viral infection of the trophoblast: time to take a serious look at its role in abnormal implantation and placentation? //J. Reprod. Immunol. – 2002. – Vol. 55. – P. 113–121.</mixed-citation><mixed-citation xml:lang="en">Arechavaleta-Velasco F., Koi H., Strauss J.F., Parry S. Viral infection of the trophoblast: time to take a serious look at its role in abnormal implantation and placentation? //J. Reprod. Immunol. – 2002. – Vol. 55. – P. 113–121.</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Romero R., Chaiworapongsa T., Espinoza J. Micronutrients and intrauterine infection, preterm birth, and the fetal inflammatory response syndrome //J. Nutr. – 2003. – Vol. 133. – P. 16668– 16673.</mixed-citation><mixed-citation xml:lang="en">Romero R., Chaiworapongsa T., Espinoza J. Micronutrients and intrauterine infection, preterm birth, and the fetal inflammatory response syndrome //J. Nutr. – 2003. – Vol. 133. – P. 16668– 16673.</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Crocker I.,. Barratt P. S, Kaur M., Baker P.N. The in-vitro characterization of induced apoptosis in placental cytotrophoblasts and syncytiotrophoblasts //Placenta. – 2001. – Vol. 22. – P. 822.</mixed-citation><mixed-citation xml:lang="en">Crocker I.,. Barratt P. S, Kaur M., Baker P.N. The in-vitro characterization of induced apoptosis in placental cytotrophoblasts and syncytiotrophoblasts //Placenta. – 2001. – Vol. 22. – P. 822.</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Chaouat G., Dubanchet S., Ledee N. Cytokines: Important for implantation? //J. Assist. Reprod. Genet. – 2007. – Vol. 24. – P. 491–505.</mixed-citation><mixed-citation xml:lang="en">Chaouat G., Dubanchet S., Ledee N. Cytokines: Important for implantation? //J. Assist. Reprod. Genet. – 2007. – Vol. 24. – P. 491–505.</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Gargano J.W., Holzman С., Senagore P. et al. Mid-pregnancy circulating cytokine levels, histologic chorioamnionitis and spontaneous preterm birth //J. Reprod. Immunol. – 2008. – Vol. 79. – P. 100–110.</mixed-citation><mixed-citation xml:lang="en">Gargano J.W., Holzman С., Senagore P. et al. Mid-pregnancy circulating cytokine levels, histologic chorioamnionitis and spontaneous preterm birth //J. Reprod. Immunol. – 2008. – Vol. 79. – P. 100–110.</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Perni S.C., Vardhana S., Tuttle S.L. et al. Fetal interleukin-1 receptor antagonist gene polymorphism, intra-amniotic interleukin-1beta levels, and history of spontaneous abortion //Am. J. Obstet. Gynecol. –2004. – Vol. 191, N 4. – P. 1318–1323.</mixed-citation><mixed-citation xml:lang="en">Perni S.C., Vardhana S., Tuttle S.L. et al. Fetal interleukin-1 receptor antagonist gene polymorphism, intra-amniotic interleukin-1beta levels, and history of spontaneous abortion //Am. J. Obstet. Gynecol. –2004. – Vol. 191, N 4. – P. 1318–1323.</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Vitoratos N., Papadias C., Economou E. et al. Elevated сirculating IL-1β and TNF-аlpha, and unaltered IL-6 in first-trimester pregnancies complicated by threatened abortion with an adverse outcome //Mediators of Inflammation. – 2006. – Article ID 30485, Р. 1-6.</mixed-citation><mixed-citation xml:lang="en">Vitoratos N., Papadias C., Economou E. et al. Elevated сirculating IL-1β and TNF-аlpha, and unaltered IL-6 in first-trimester pregnancies complicated by threatened abortion with an adverse outcome //Mediators of Inflammation. – 2006. – Article ID 30485, Р. 1-6.</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Phillips D.J., Jones K.L., Clarke I.J. et al. Activin A: from sometime reproductive factor to genuine cytokine //Vet. Immunol. Immunopathol. – 2005. – Vol. 108, N 1/2. – P. 23–27.</mixed-citation><mixed-citation xml:lang="en">Phillips D.J., Jones K.L., Clarke I.J. et al. Activin A: from sometime reproductive factor to genuine cytokine //Vet. Immunol. Immunopathol. – 2005. – Vol. 108, N 1/2. – P. 23–27.</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Florio P., Severi F.M., Bocchi C. et al. Single serum activin a testing to predict ectopic pregnancy //J. Clin. Endocrinol. Metab. – 2007. – Vol. 92. – P. 1748–1753.</mixed-citation><mixed-citation xml:lang="en">Florio P., Severi F.M., Bocchi C. et al. Single serum activin a testing to predict ectopic pregnancy //J. Clin. Endocrinol. Metab. – 2007. – Vol. 92. – P. 1748–1753.</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Minas V., Jeschke U., Kalantaridou S.N. et al. Abortion is associated with increased expression of FasL in decidual leukocytes and apoptosis of extravillous trophoblasts: a role for CRH and urocortin //Molecular Human Reproduction. –2007. – Vol. 13, N 9 – P. 663–673.</mixed-citation><mixed-citation xml:lang="en">Minas V., Jeschke U., Kalantaridou S.N. et al. Abortion is associated with increased expression of FasL in decidual leukocytes and apoptosis of extravillous trophoblasts: a role for CRH and urocortin //Molecular Human Reproduction. –2007. – Vol. 13, N 9 – P. 663–673.</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
